Cite
HARVARD Citation
Bao, X. et al. (2015). Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bao, X. et al. (2015). Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].